Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Transurethral bipolar plasmakinetic prostatectomy for benign prostatic hyperplasia].

Jiansheng Lai1, Qiang Xia, Shengli Xu

  • 1Department of Urology, Jiangmen People's Hospital, Jiangmen, Guangdong 529051, China. jslai@medmail.com.cn

Zhonghua Nan Ke Xue = National Journal of Andrology
|September 10, 2004
PubMed
Summary

Transurethral plasmakinetic prostatectomy (TUPKP) is a safe and effective treatment for benign prostatic hyperplasia (BPH). This procedure significantly improves urinary flow and quality of life with minimal complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Occlusion-Aware Trajectory Discontinuity Correction for Roadside LiDAR Using Time-Space Analysis.

Sensors (Basel, Switzerland)·2026
Same author

A Hidden "Promoter": <i>Schistosoma japonicum</i> soluble egg antigen activates MAPK/PI3K-AKT pathways and inhibits autophagy to facilitate colorectal cancer.

Infection and immunity·2026
Same author

NAT10 promotes the activation of hepatic stellate cells by modulating the TGF-β1-ac4C-COL1A1 axis.

Hepatology international·2026
Same author

WASH regulates B cell signaling, metabolism and function through STAT1.

Cell death and differentiation·2025
Same author

AIM2 positively regulates B cell activation and function through the SNX9-PI3K-WASP axis.

Cell death and differentiation·2025
Same author

Ivermectin attenuates <i>Schistosoma japonicum</i>-induced liver fibrosis and is associated with downregulation of YAP signaling.

Frontiers in cellular and infection microbiology·2025

Area of Science:

  • Urology
  • Surgical Innovation
  • Benign Prostatic Hyperplasia Management

Context:

  • Benign prostatic hyperplasia (BPH) is a common condition in aging men, leading to lower urinary tract symptoms.
  • Traditional surgical interventions carry risks of complications and prolonged recovery.
  • Transurethral plasmakinetic prostatectomy (TUPKP) has emerged as an alternative surgical technique.

Purpose:

  • To evaluate the efficacy and safety of transurethral plasmakinetic prostatectomy (TUPKP) for treating BPH.
  • To assess the perioperative outcomes and complications associated with TUPKP.
  • To determine the long-term functional improvements in patients undergoing TUPKP.

Summary:

  • A study involving 313 patients undergoing TUPKP for BPH recorded operative and blood indexes.

Related Experiment Videos

  • Follow-up at 1 month, 3 months, and 1 year assessed maximum urinary flow rate (Qmax), International Prostate Symptom Score (IPSS), and Quality of Life (QOL).
  • Results showed significant improvements in Qmax, IPSS, and QOL, with minimal blood loss and no TUR syndrome.

    • Impact:

    • TUPKP demonstrates a favorable safety profile with significantly fewer complications compared to other methods.
    • The procedure leads to substantial and sustained improvements in urinary flow and symptom scores.
    • TUPKP is a recommended, effective surgical option for managing benign prostatic hyperplasia.